Key Takeaways
Citizens analyst Reni Benjamin initiates coverage on Compass Therapeutics (CMPX) with a “Market Outperform” rating. Current price target s
CMPX Analyst Rating Update: Citizens Initiates Coverage with Market Outperform
Dec 3, 2025
![i’m-nervous,-too!-[part-2]](https://10xwealthreport.com/wp-content/uploads/2026/03/177042-im-nervous-too-part-2-1568x784.jpg)
